Ali Jahanshahi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ali Jahanshahi has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Mohammad Amin Salehi
McGill University Health Centre, Montreal, QC H4A 0B1, Canada
2 shared publications - Abinash Mahapatro
SIU School of Medicine, Springfield, IL, USA
1 shared publication Ali Guermazi
Affiliation Department of Radiology, VA Boston Healthcare System, Boston University School of Medicine, Boston, Massachusetts, United States of America
1 shared publication- Ali Guermazi
Department of Radiology, Boston University School of Medicine, Boston, Mass
1 shared publication Azam Yalameh Aliabadi
Faculty of Medicine, Guilan University of Medical Sciences, Rasht, Iran
1 shared publication- Azin Alizadehasl
Cardio‐Oncology Research Center Rajaie Cardiovascular Medical and Research Institute Tehran Iran
1 shared publication
Latest Publications
- 24 November 2025
- Published by Wiley in Journal of Clinical Ultrasound
- Vol. 54 (4) , 889-903
High‐Intensity Focused Ultrasound in Treatment of Primary Breast Cancer: A Systematic Review and Meta‐Analysis
Background: In recent years, tumor management strategies have focused on less invasive methods, aiming to yield optimal efficacy while minimizing further complications and enhancing the overall outcome of patients. High‐intensity focused ultrasound (HIFU), a known thermal ablative technique, has shown promising results in breast cancer treatment. Therefore, we performed this systematic review and meta‐analysis to assess the clinical, histopathologic, immunologic, and radiologic outcomes of HIFU ablative therapy and its complications in patients with primary breast cancer. Methods: We searched PubMed and Scopus databases to identify the eligible articles. Data extraction was conducted by two independent authors. A random effects model was employed to pool the proportion of remaining tumor after HIFU therapy in breast cancer. A subgroup analysis was performed according to imaging guidance modality and study design. Moreover, the heterogeneity and bias were assessed using funnel plot, Egger's regression plot, and Baujat plot. Pooled CD4/CD8 ratio mean difference between HIFU and radical mastectomy was measured using a fixed‐effect model. Results: We included 26 studies and 677 participants in the systematic review. Tumor necrosis rates varied, with 4 studies reporting less than 50% complete necrosis and 5 more than 50%. Two studies observed HIFU‐induced disturbances in the microvasculature of the targeted tissue. Six noted no contrast enhancement in successfully treated areas, two observed a thin rim indicating necrosis or fibrosis, and four reported a persistent enhancement in MRI images associated with a residual viable tumor. The weighted proportion of patients with residual tumor was 0.59 (95% CI; 0.44–0.73). The subgroup analysis demonstrated that although the pooled proportion of ultrasound‐guided studies was notably higher than magnetic resonance imaging‐guided studies (0.71 vs. 0.57), the between‐group difference was not statistically significant ( p = 0.1693). The diagnostic tools showed that the results are driven by certain studies, and there is also a potential small‐study effect. Furthermore, the CD4/CD8 ratio was higher in the HIFU group, with a weighted mean difference of 0.6 (95% CI: 0.41–0.78). The most prevalent side effects were pain (47.14%) and skin burn (2.59%). Conclusions: HIFU is a relatively safe procedure for the treatment of breast cancer as an independent or conjugated therapy and its effectiveness is promising regarding histopathological response, immunological reactivity, and vascular damage in the targeted area.
- 24 November 2025
- Published by Wiley in Journal of Clinical Ultrasound
- Vol. 54 (4) , 889-903
High‐Intensity Focused Ultrasound in Treatment of Primary Breast Cancer: A Systematic Review and Meta‐Analysis
Background: In recent years, tumor management strategies have focused on less invasive methods, aiming to yield optimal efficacy while minimizing further complications and enhancing the overall outcome of patients. High‐intensity focused ultrasound (HIFU), a known thermal ablative technique, has shown promising results in breast cancer treatment. Therefore, we performed this systematic review and meta‐analysis to assess the clinical, histopathologic, immunologic, and radiologic outcomes of HIFU ablative therapy and its complications in patients with primary breast cancer. Methods: We searched PubMed and Scopus databases to identify the eligible articles. Data extraction was conducted by two independent authors. A random effects model was employed to pool the proportion of remaining tumor after HIFU therapy in breast cancer. A subgroup analysis was performed according to imaging guidance modality and study design. Moreover, the heterogeneity and bias were assessed using funnel plot, Egger's regression plot, and Baujat plot. Pooled CD4/CD8 ratio mean difference between HIFU and radical mastectomy was measured using a fixed‐effect model. Results: We included 26 studies and 677 participants in the systematic review. Tumor necrosis rates varied, with 4 studies reporting less than 50% complete necrosis and 5 more than 50%. Two studies observed HIFU‐induced disturbances in the microvasculature of the targeted tissue. Six noted no contrast enhancement in successfully treated areas, two observed a thin rim indicating necrosis or fibrosis, and four reported a persistent enhancement in MRI images associated with a residual viable tumor. The weighted proportion of patients with residual tumor was 0.59 (95% CI; 0.44–0.73). The subgroup analysis demonstrated that although the pooled proportion of ultrasound‐guided studies was notably higher than magnetic resonance imaging‐guided studies (0.71 vs. 0.57), the between‐group difference was not statistically significant ( p = 0.1693). The diagnostic tools showed that the results are driven by certain studies, and there is also a potential small‐study effect. Furthermore, the CD4/CD8 ratio was higher in the HIFU group, with a weighted mean difference of 0.6 (95% CI: 0.41–0.78). The most prevalent side effects were pain (47.14%) and skin burn (2.59%). Conclusions: HIFU is a relatively safe procedure for the treatment of breast cancer as an independent or conjugated therapy and its effectiveness is promising regarding histopathological response, immunological reactivity, and vascular damage in the targeted area.
- Open Access
- 24 June 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (6) , e0326339
Diagnosis of knee meniscal injuries using artificial intelligence: A systematic review and meta-analysis of diagnostic performance
Aim of the study: The aim was to systematically review the literature and perform a meta-analysis to estimate the performance of artificial intelligence (AI) algorithms in detecting meniscal injuries. Materials and methods: A systematic search was performed in the Scopus, PubMed, EBSCO, Cinahl, Web of Science, IEEE Xplore, and Cochrane Central databases on July, 2024. The included studies’ reporting quality and risk of bias were evaluated using the Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD) and the Prediction Model Study Risk of Bias Assessment Tool (PROBAST), respectively. Also, a meta-analysis was done using contingency tables to estimate diagnostic performance metrics (sensitivity and specificity), and a meta-regression analysis was performed to investigate the effect of the following variables on the main outcome: imaging view, data augmentation and transfer learning usage, and presence of meniscal tear in the injury, with a corresponding 95% confidence interval (CI) and a P-value of 0.05 as a threshold for significance. Results: Among 28 included studies, 92 contingency tables were extracted from 15 studies. The reference standard of the studies were mostly expert radiologists, orthopedics, or surgical reports. The pooled sensitivity and specificity for AI algorithms on internal validation were 81% (95% CI: 78, 85), and 78% (95% CI: 72, 83), and for clinicians on internal validation were 85% (95% CI: 76, 91), and 88% (95% CI: 83, 92), respectively. The pooled sensitivity and specificity for studies validating algorithms with an external test set were 82% (95% CI: 74, 88), and 88% (95% CI: 84, 91), respectively. Conclusion: The results of this study imply the lower diagnostic performance of AI-based algorithms in knee meniscal injuries compared with clinicians.
- 24 June 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (6) , e0326339
Open AccessDiagnosis of knee meniscal injuries using artificial intelligence: A systematic review and meta-analysis of diagnostic performance
Aim of the study: The aim was to systematically review the literature and perform a meta-analysis to estimate the performance of artificial intelligence (AI) algorithms in detecting meniscal injuries. Materials and methods: A systematic search was performed in the Scopus, PubMed, EBSCO, Cinahl, Web of Science, IEEE Xplore, and Cochrane Central databases on July, 2024. The included studies’ reporting quality and risk of bias were evaluated using the Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD) and the Prediction Model Study Risk of Bias Assessment Tool (PROBAST), respectively. Also, a meta-analysis was done using contingency tables to estimate diagnostic performance metrics (sensitivity and specificity), and a meta-regression analysis was performed to investigate the effect of the following variables on the main outcome: imaging view, data augmentation and transfer learning usage, and presence of meniscal tear in the injury, with a corresponding 95% confidence interval (CI) and a P-value of 0.05 as a threshold for significance. Results: Among 28 included studies, 92 contingency tables were extracted from 15 studies. The reference standard of the studies were mostly expert radiologists, orthopedics, or surgical reports. The pooled sensitivity and specificity for AI algorithms on internal validation were 81% (95% CI: 78, 85), and 78% (95% CI: 72, 83), and for clinicians on internal validation were 85% (95% CI: 76, 91), and 88% (95% CI: 83, 92), respectively. The pooled sensitivity and specificity for studies validating algorithms with an external test set were 82% (95% CI: 74, 88), and 88% (95% CI: 84, 91), respectively. Conclusion: The results of this study imply the lower diagnostic performance of AI-based algorithms in knee meniscal injuries compared with clinicians.
- Open Access
- 7 March 2025
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 87 (4) , 2263-2277
The impact of gut microbiome modulation on anthropometric indices in metabolic syndrome: an umbrella review
Background: Metabolic syndrome (MetS) is a complex disorder characterized by a cluster of metabolic risk factors. Recent research highlights the gut microbiome’s role in metabolic regulation, suggesting that modulation through probiotics, prebiotics, and synbiotics may provide a novel approach to managing MetS. This umbrella review aims to integrate insights from existing meta-analyses to explore how changes in gut microbiota influence key body measurement indicators in individuals with MetS. Methods: A systematic search of PubMed, Scopus, and Web of Science databases identified meta-analyses that assessed the impact of probiotics, prebiotics, or synbiotics on anthropometric indices in MetS patients. Results: The results indicated that microbial therapy leads to a significant reduction in body mass index (BMI) (SMD: −0.22; 95% CI: −0.35 to −0.09; P < 0.01) and waist circumference (WC) (SMD: −0.47; 95% CI: −0.80 to −0.15; P < 0.01). However, microbial therapy did not significantly affect body fat mass (SMD: −0.30; 95% CI: −0.64 to 0.02; P = 0.06), body fat percentage (SMD: −0.29; 95% CI: −0.62 to 0.03; P = 0.07), waist-to-hip ratio (SMD: −0.09; 95% CI: −0.46 to 0.28; P = 0.63), and weight (SMD: −0.06; 95% CI: −0.21 to 0.08; P = 0.37). Conclusions: Gut microbial modulation, mainly through probiotics and synbiotics, shows promise in reducing BMI and WC in MetS patients. However, its effects on other anthropometric indices remain uncertain, warranting further high-quality research to fully understand microbial interventions’ therapeutic potential.
- 7 March 2025
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 87 (4) , 2263-2277
Open AccessThe impact of gut microbiome modulation on anthropometric indices in metabolic syndrome: an umbrella review
Background: Metabolic syndrome (MetS) is a complex disorder characterized by a cluster of metabolic risk factors. Recent research highlights the gut microbiome’s role in metabolic regulation, suggesting that modulation through probiotics, prebiotics, and synbiotics may provide a novel approach to managing MetS. This umbrella review aims to integrate insights from existing meta-analyses to explore how changes in gut microbiota influence key body measurement indicators in individuals with MetS. Methods: A systematic search of PubMed, Scopus, and Web of Science databases identified meta-analyses that assessed the impact of probiotics, prebiotics, or synbiotics on anthropometric indices in MetS patients. Results: The results indicated that microbial therapy leads to a significant reduction in body mass index (BMI) (SMD: −0.22; 95% CI: −0.35 to −0.09; P < 0.01) and waist circumference (WC) (SMD: −0.47; 95% CI: −0.80 to −0.15; P < 0.01). However, microbial therapy did not significantly affect body fat mass (SMD: −0.30; 95% CI: −0.64 to 0.02; P = 0.06), body fat percentage (SMD: −0.29; 95% CI: −0.62 to 0.03; P = 0.07), waist-to-hip ratio (SMD: −0.09; 95% CI: −0.46 to 0.28; P = 0.63), and weight (SMD: −0.06; 95% CI: −0.21 to 0.08; P = 0.37). Conclusions: Gut microbial modulation, mainly through probiotics and synbiotics, shows promise in reducing BMI and WC in MetS patients. However, its effects on other anthropometric indices remain uncertain, warranting further high-quality research to fully understand microbial interventions’ therapeutic potential.
- 18 October 2023
- Published by Elsevier in Osteoarthritis and Cartilage
- Vol. 32 (3) , 241-253
Artificial intelligence in osteoarthritis detection: A systematic review and meta-analysis
- 18 October 2023
- Published by Elsevier in Osteoarthritis and Cartilage
- Vol. 32 (3) , 241-253
Artificial intelligence in osteoarthritis detection: A systematic review and meta-analysis
- Open Access
- 6 October 2023
- Published by Brieflands in Iranian Journal of Radiology
- Vol. 20 (3)
Application of Elastography in the Diagnosis of Idiopathic Granulomatous Mastitis (IGM): A Systematic Review
Context: Idiopathic granulomatous mastitis (IGM) is a benign inflammatory condition of the breasts with an unknown etiology, which can mimic breast cancer on conventional ultrasound. Other imaging modalities, such as mammography and magnetic resonance imaging, cannot efficiently differentiate this condition from malignancies. Elastography is a novel imaging technique used to evaluate tissue elasticity. Objectives: This systematic review aimed to investigate the imaging features of IGM on elastography and also to determine whether this modality is useful for distinguishing IGM from other breast malignancies. Materials and Methods: A comprehensive literature search was conducted across several databases, including Medline, Embase, Cochrane Library, Scopus, and Web of Science, in October 2022. The Joanna Briggs Institute (JBI) critical appraisal tool was used for the quality assessment of the studies. Results: After screening 851 articles, seven studies investigating ultrasound elastography were found to meet the inclusion criteria. Regarding the quantitative findings, both the strain ratio and shear wave velocity were observed to be higher in malignant masses as compared to IGM. Additionally, qualitative scoring systems, such as the Tsukuba and Tozaki classifications, assigned higher scores to malignant lesions. Five of the included studies in this review proposed a specific cut-off point for differentiating IGM from malignancies, using either shear wave velocity, strain ratio, or elasticity scores. In four of the studies, these criteria exhibited sensitivity and specificity of approximately 90%. Conclusion: The current findings suggest that ultrasound elastography can serve as a valuable tool for distinguishing IGM from breast malignancies. By potentially reducing the number of unnecessary tissue biopsies, this modality may lead to a more efficient patient evaluation process.
- 6 October 2023
- Published by Brieflands in Iranian Journal of Radiology
- Vol. 20 (3)
Open AccessApplication of Elastography in the Diagnosis of Idiopathic Granulomatous Mastitis (IGM): A Systematic Review
Context: Idiopathic granulomatous mastitis (IGM) is a benign inflammatory condition of the breasts with an unknown etiology, which can mimic breast cancer on conventional ultrasound. Other imaging modalities, such as mammography and magnetic resonance imaging, cannot efficiently differentiate this condition from malignancies. Elastography is a novel imaging technique used to evaluate tissue elasticity. Objectives: This systematic review aimed to investigate the imaging features of IGM on elastography and also to determine whether this modality is useful for distinguishing IGM from other breast malignancies. Materials and Methods: A comprehensive literature search was conducted across several databases, including Medline, Embase, Cochrane Library, Scopus, and Web of Science, in October 2022. The Joanna Briggs Institute (JBI) critical appraisal tool was used for the quality assessment of the studies. Results: After screening 851 articles, seven studies investigating ultrasound elastography were found to meet the inclusion criteria. Regarding the quantitative findings, both the strain ratio and shear wave velocity were observed to be higher in malignant masses as compared to IGM. Additionally, qualitative scoring systems, such as the Tsukuba and Tozaki classifications, assigned higher scores to malignant lesions. Five of the included studies in this review proposed a specific cut-off point for differentiating IGM from malignancies, using either shear wave velocity, strain ratio, or elasticity scores. In four of the studies, these criteria exhibited sensitivity and specificity of approximately 90%. Conclusion: The current findings suggest that ultrasound elastography can serve as a valuable tool for distinguishing IGM from breast malignancies. By potentially reducing the number of unnecessary tissue biopsies, this modality may lead to a more efficient patient evaluation process.